Product Information
BREO ELLIPTA 100-25 MCG INHALR is a brand product labeled by GlaxoSmithKline LLC, priced at $5.3576 per EA under NDC 00173085914. Its NADAC has been published 634 times since Apr 23, 2014.
Strength
100; 25 ug/1; ug/1
Manufacturer
GlaxoSmithKline LLCNDC
00173085914
Classification
Brand
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
FLUTICASONE FUROATE; VILANTEROL TRIFENATATEApproval Type
New Drug (NDA)
FDA Application
NDA204275On Market Since
8/26/2013
Pharmacological Classes
Price Statistics
The NADAC for BREO ELLIPTA 100-25 MCG INHALR has been published 634 times since Apr 23, 2014, and over the history we have for it it has risen 51.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.3576 per EA |
|---|---|
| All-time high | $5.3987 (May 15, 2024) |
| All-time low | $3.5340 (Apr 23, 2014) |
| 52-week high | $5.3857 |
| 52-week low | $5.3576 |
| Median price | $4.7946 |
| Average price | $4.6802 |
| Largest weekly change | +8.0% (Jan 11, 2017) |
| Weeks tracked | 634 |
| Tracking since | Apr 23, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BREO ELLIPTA 100-25 MCG INHALR?
The current National Average Drug Acquisition Cost (NADAC) for BREO ELLIPTA 100-25 MCG INHALR, manufactured by GlaxoSmithKline LLC, is $5.3576 per EA (NDC 00173085914), effective Jun 24, 2026.
How has the price of BREO ELLIPTA 100-25 MCG INHALR changed over time?
Over the history we have for it, the NADAC for BREO ELLIPTA 100-25 MCG INHALR has risen 51.6%. It has been tracked across 634 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for BREO ELLIPTA 100-25 MCG INHALR?
Since Apr 23, 2014, the NADAC for BREO ELLIPTA 100-25 MCG INHALR has ranged from a low of $3.5340 (Apr 23, 2014) to a high of $5.3987 (May 15, 2024), with a median of $4.7946 per EA.
Are there cheaper alternatives to BREO ELLIPTA 100-25 MCG INHALR?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BREO ELLIPTA 100-25 MCG INHALR, but none are currently priced below it.
Who manufactures BREO ELLIPTA 100-25 MCG INHALR?
BREO ELLIPTA 100-25 MCG INHALR (NDC 00173085914) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification